CSIMarket Company Name, Ticker, Customers, else..


Radnet Inc   (NASDAQ: RDNT)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Radnet Inc

RDNT's Fundamental analysis



Looking into Radnet Inc growth rates, revenue grew by 14.22 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 810

Medical Laboratories industry recorded growth of revenues by 6.58 %

Radnet Inc 's net profit decreased by -15.81 % in III. Quarter 2024 year on year, to $12 millions.

• More on RDNT's Growth


Radnet Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Radnet Inc PEG ratio is at -1.6 Company is currently trading with Price to Cash flow multiple of 12.12 in trailing twelve-month period.
Company
297.71
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.68.
Medical Laboratories industry's Price to Sales ratio is at 2.51.


• More on RDNT's Valuation
 
 Total Debt (Millions $) 1,020
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 222,882
 Net Income/Employee (TTM) $ 6,184
 Receivable Turnover (TTM) 9.34
 Tangible Book Value (Per Share $) 4.30

Radnet Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Radnet Inc PEG ratio is at -1.6 Company is currently trading with Price to Cash flow multiple of 12.12 in trailing twelve-month period.
Company
297.71
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.68.
Medical Laboratories industry's Price to Sales ratio is at 2.51.

Radnet Inc Price to Book Ratio is at 4.2 lower than Industry Avg. of 357.33. and higher than S&P 500 Avg. of 0.02

• More on RDNT's Valuation

•  Market Capitalization (Millions $) 4,699
•  Shares Outstanding (Millions) 75
•  Employees 7,872
•  Revenues (TTM) (Millions $) 1,755
•  Net Income (TTM) (Millions $) 49
•  Cash Flow (TTM) (Millions $) 388
•  Capital Exp. (TTM) (Millions $) -225
•  Total Debt (Millions $) 1,020
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 222,882
•  Net Income/Employee(TTM) $ 6,184
•  Receivable Turnover Ratio (TTM) 9.34
•  Tangible Book Value (Per Share $) 4.30

•  Market Capitalization (Millions $) 4,699
•  Shares Outstanding (Millions) 75
•  Employees 7,872
•  Revenues (TTM) (Millions $) 1,755
•  Net Income (TTM) (Millions $) 49
•  Cash Flow (TTM) (Millions $) 388
•  Capital Exp. (TTM) (Millions $) -225


    RDNT's Profitability Comparisons
Radnet Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 7.35 % from 7.58 % in II. Quarter.

Radnet Inc net profit margin of 2.66 % is currently ranking no. 11 in Medical Laboratories industry, ranking no. 177 in Healthcare sector and number 2056 in S&P 500.


Profitability by Segment
Total 2.66 %



  Ratio
•   Capital Ratio (MRQ) 2.26
•  Total Debt to Equity (MRQ) 0.91
•  Tangible Leverage Ratio (MRQ) 7.36
•  Asset Turnover Ratio (TTM) 0.56
•  Inventory Turnover Ratio (TTM) -



Radnet Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 7.35 % from 7.58 % in II. Quarter.

Radnet Inc net profit margin of 2.66 % is currently ranking no. 11 in Medical Laboratories industry, ranking no. 177 in Healthcare sector and number 2056 in S&P 500.

• More on RDNT's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com